State Key Laboratory of Biocatalysis and Enzyme Engineering & Collaborative Innovation Center for Advanced Organic Chemical Materials Co-Constructed by the Province and Ministry, Hubei University, Wuhan 430062, China.
Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
ACS Appl Bio Mater. 2022 Aug 15;5(8):3923-3935. doi: 10.1021/acsabm.2c00449. Epub 2022 Jul 22.
Tissue-engineered heart valves (TEHVs) are the most promising replacement for heart valve transplantation. Decellularized heart valve (DHV) is one of the most common scaffold materials for TEHVs. In actual clinical applications, the most widely used method for treating DHV is cross-linking it with glutaraldehyde, but this method could cause serious problems such as calcification. In this study, we introduced polyhedral oligomeric silsesquioxane (POSS) nanoparticles into a poly(ethylene glycol) (PEG) hydrogel to prepare a POSS-PEG hybrid hydrogel, and then coated them on the surface of DHV to prepare the composite scaffold. The chemical structures, microscopic morphologies, cell compatibilities, blood compatibilities, and anticalcification properties were further investigated. Experimental results showed that the composite scaffold had good blood compatibility and excellent cell compatibility and could promote cell adhesion and proliferation. In vivo and in vitro anticalcification experiments showed that the introduction of POSS nanoparticles could reduce the degree of calcification significantly and the composite scaffold had obvious anticalcification ability. The DHV surface-coated with the POSS-PEG hybrid hydrogel is an alternative scaffold material with anticalcification potential for an artificial heart valve, which provides an idea for the preparation of TEHVs.
组织工程心脏瓣膜(TEHV)是心脏瓣膜移植最有前途的替代品。脱细胞心脏瓣膜(DHV)是 TEHV 最常用的支架材料之一。在实际临床应用中,最广泛使用的处理 DHV 的方法是用戊二醛交联它,但这种方法可能会导致严重的问题,如钙化。在本研究中,我们将多面体低聚倍半硅氧烷(POSS)纳米粒子引入聚乙二醇(PEG)水凝胶中,制备 POSS-PEG 杂化水凝胶,然后将其涂覆在 DHV 表面,制备复合支架。进一步研究了其化学结构、微观形貌、细胞相容性、血液相容性和抗钙化性能。实验结果表明,该复合支架具有良好的血液相容性和优异的细胞相容性,能促进细胞黏附和增殖。体内和体外抗钙化实验表明,引入 POSS 纳米粒子能显著降低钙化程度,该复合支架具有明显的抗钙化能力。DHV 表面涂覆 POSS-PEG 杂化水凝胶是一种具有抗钙化潜力的人工心脏瓣膜替代支架材料,为 TEHV 的制备提供了思路。